Indiva Q&A
Don’t say I did not warn you about no fluff from me! With just under 81M shares issued and outstanding (and a market cap of about $55M at time of writing), can you advise what percent of those shares are held by insiders? Fully diluted, there are 122.9M shares outstanding. What are the cash proceeds expected from all sources if this full dilution is realized?
Readers – with this information you can work backwards to determine the number of shares in the public float.
Insiders represent some 25% of basic shares outstanding. On a fully-diluted basis, an additional $30 million would come into the company’s treasury (which is currently some $26 million).
In time, what do you see as the product line of choice by customers? I think your website and corporate presentation may be a strong indicator with sugar and edible lines planned. What about beverages?
OK … and another not so easy question. The Canadian Medical Association has stated that the Federal Government should phase out the medical-use framework (Click Here). As a Licensed Producer first and foremost what are your thoughts on the position of the CMA particularly given your published relationships with the London Compassionate Society to transfer up to 1200 patients and your strong binds with the medical community?
Our view is that patients should have as much access as possible to the medical cannabis they require. Some 300,000 patients with prescriptions are currently signed up with LPs, so eliminating the medical-use framework may be easier said than done. Regardless, we know many LCS patients rely on the strains our Master Grower cultivates, and our goal is continue to provide these trusted strains to all of our clients, regardless of the channel they access INDIVA product.
66